SCHEMBL29633905

SCHEMBL29633905

COc1ccc(CC(C(=O)OC(C)(C)C)N(C)C(=O)OCC2c3ccccc3-c3ccccc32)cn1

nearest known ligand 0.37

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FABP5 Q01469 2/20 0.37
TAS2R14 Q9NYV8 1/20 0.33
KLKB1 P03952 1/20 0.33
CHRM1 P11229 1/20 0.32
KMT2A Q03164 2/20 0.32
MDM2 Q00987 1/20 0.32
ITGB3 P05106 1/20 0.32
ITGA2B P08514 1/20 0.32
NPC1 O15118 1/20 0.32
LMNA P02545 1/20 0.32
PKM P14618 1/20 0.32
MEN1 O00255 1/20 0.31
FABP7 O15540 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25657534 1.00 FABP5 (0.37) FABP5TAS2R14KLKB1CHRM1KMT2A
SCHEMBL29633829 0.91 FABP5 (0.36) FABP5TAS2R14CHRM1KMT2AMDM2
SCHEMBL29633737 0.89 FABP5 (0.34) FABP5KMT2AMDM2ITGB3ITGA2B
SCHEMBL25657535 0.89 FABP5 (0.34) FABP5KMT2AMDM2ITGB3ITGA2B
SCHEMBL25183125 0.89 FABP5 (0.41) FABP5TAS2R14KLKB1KMT2AMDM2
SCHEMBL25182963 0.89 FABP5 (0.41) FABP5TAS2R14KLKB1KMT2AMDM2
SCHEMBL30054744 0.89 FABP5 (0.41) FABP5TAS2R14KLKB1KMT2AMDM2
SCHEMBL25355198 0.89 FABP5 (0.41) FABP5TAS2R14KLKB1KMT2AMDM2
SCHEMBL29633739 0.89 FABP5 (0.41) FABP5TAS2R14KLKB1KMT2AMDM2
SCHEMBL25657531 0.87 KCNH2 (0.33) KMT2AMDM2ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2024-11-14 US disclosed
US-12071396-B2 Method for preparing aromatic amino acid derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-08-27 US disclosed
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR FABP5 608/4885TAS2R14 3521/4885KLKB1 3826/4885
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR FABP5 608/4885TAS2R14 3521/4885KLKB1 3826/4885
US-12071396-B2 Method for preparing aromatic amino acid derivative DDC, AADAT, TYR FABP5 608/4885TAS2R14 3521/4885KLKB1 3826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.